CompletedPhase 4

Effectiveness of Repeated Amiodarone Dosing Regimen Versus Standard Dosing Regimen in Atrial Fibrillation Patient With Rapid Ventricular Response

Thailand24 participantsStarted 2024-05-01

Plain-language summary

The goal of this clinical trial is to compare in atrial fibrillation patient with rapid ventricular response. The main question it aims to answer are Effectiveness of Repeated Amiodarone dosing regimen versus standard dosing regimen in Atrial fibrillation patient with rapid ventricular response Participants will receive Amiodarone iv treatment with different regimen * Repeated dosing regimen * Standard dosing regimen

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age above 18 years old * Atrial fibrillation with rapid ventricular response patient (ventricular rate \> 110) Exclusion Criteria: * Baseline EKG Corrected QT interval (QTc) \< 500 msec * History of pulmonary fibrosis * History of Cirrhosis * Cardiac Index \<2.2 L/min/m2 or Cardiogenic shock * Unstable arrhythmia * Receive amiodarone within 3 months prior to present illness * Pregnancy * Amiodarone or Iodine allergy

What they're measuring

Heart rate

Timeframe: 6-hours after receiving amiodarone bolus

Trial details

NCT IDNCT06262932

SponsorPolice General Hospital, Thailand

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Atrial Fibrillation trials